NCT00003706View on ClinicalTrials.gov

LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

pemetrexed disodium

Trial Locations (1)

78229-3264

San Antonio Cancer Institute, San Antonio

Sponsors
All Listed Sponsors
collaborator

Lily Research Laboratories

UNKNOWN

collaborator

National Cancer Institute (NCI)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER